ミネソタ州における食道腺癌の臨床試験
ミネソタ州内の拠点で、食道腺癌に関する14件の研究が参加者を募集しています。
ミネソタ州内の都市
公式研究テキスト（英語）
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Mercy Hospital, Coon Rapids
- 他12件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Sanford Joe Lueken Cancer Center, Bemidji
- 他46件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Mayo Clinic in Rochester, Minnesota, Rochester
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Research Site, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06005493Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Mayo Clinic, Rochester
被験者募集中
18歳〜89歳 · 全性別 · 2026/09/11更新 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Burnsville
- Research Site, Duluth
- Research Site, Minneapolis
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Minneapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- M Health Fairview University of Minnesota Medical Center, Minneapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- Allina Health Cancer Institute - United Hospital, Saint Paul
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Mayo Clinic, Rochester
被験者募集中
18歳〜89歳 · 全性別 · 2026/07/01更新 · NCT05530343Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
- Mayo Clinic in Rochester, Rochester
被験者募集中
18歳〜90歳 · 全性別 · 2026/06/02更新 · NCT06071845A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/08更新 · NCT05954312Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- Mayo Clinic Health Systems - Austin, Austin
- Mayo Clinic Rochester, Rochester
被験者募集中健康なボランティア歓迎
18歳〜90歳 · 全性別 · 2026/01/26更新 · NCT03961945ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。